Skip to main content
SpringerLink
Log in

Hämostaseologie und Einflußfaktoren auf Entstehung und Verlauf von Gefäßkrankheiten

  • Chapter
Arterien und Venen

Part of the book series: Klinische Radiologie ((KLINRAD))

  • 72 Accesses

Zusammenfassung

Zwischen dem Blutstillungssystem und der Pathogenese von arteriellen und venösen Gefäßkrankheiten bestehen vielfältige Beziehungen. In den letzten Jahren haben neue experimentelle Daten unser Verständnis der Beziehungen zwischen Hämostasefaktoren und Gefäßwand bei der Atherogenese wesentlich erweitert. Aber auch zur venösen Thrombogenese gibt es wichtige neue Befunde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinand E, Wolf M, Meyer D (1992) Platelet factor 4 complexed to Heparin is the target for antibodies generated in Heparin-induced thrombocytopenia. Thromb Haemostas 68:95–96

    CAS  Google Scholar 

  2. Balsano F, Coccheri S, Libretti A et al (1989) Ticlopidine in the treatment of intermittent claudication: A 21 month double blind trial. J Lab Clin Med 114:84–91

    PubMed  CAS  Google Scholar 

  3. Bauriedel G, Windstetter U, de Maio SJ, Kandolf R, Höfling B (1992) Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy. Circulation 85: 554–564

    PubMed  CAS  Google Scholar 

  4. Bauriedal G, Kandolf R, Welsch U, Höfling B (1994) Mechanismen der Restenose nach Angioplastie. Kardiol Z 83 (Suppl 4): 31–41

    Google Scholar 

  5. Bollinger A, Schneider E, Pouliadis G, Torres C, Brunner U (1981) Thrombozytenfunktionshemmer und Antikoagulanzien nach gefäßrekonstruktiven Eingriffen im femoropoplitealen Bereich. In: Breddin K (Hrsg) Thrombose und Atherogenese, Risikofaktoren bei gefäßchirurgischen Eingriffen, Beckenthrombose. Witzstrock, Baden-Baden Köln New York, S 276–279

    Google Scholar 

  6. Breddin HK, Krzywanek HJ, Althoff P, Kirchmaier CM, Rosak C, Schepping M, Weichert W, Ziemen M, Schoffling K, Überla K (1986) Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occulsions in diabetics. Int Angiol 5:181–195

    PubMed  CAS  Google Scholar 

  7. Bruhn HD, Jipp P, Schellmann J, Sedlmayer S, Müller-Wiefel H, Borm D (1972) Zur Antikoagulanzienprophylaxe bei chirurgischer und konservativer Therapie chronischer Becken-Bein-Arterienverschlüsse. Med Klin 67:1514–1519

    PubMed  CAS  Google Scholar 

  8. Brunner U, Bollinger A, Schneider E, Witschi BB (1979) Endarteriektomie und autologer Venenbypass: Rezidivprophylaxe mit Aggregationshemmern und Antikoagulanzien. In: Wagener O, Kubina VK (Hrsg) Der Rezidiwerschluß nach Gefäßkonstruktionen an der unteren Extremität. Egermann, Wien, S 99–107

    Google Scholar 

  9. Buda JA, Weber CJ, McAllister EF, Voorhees AB (1970) Factors influencing patency of femoropopliteal artery bypass grafts. Am J Surg 120:8–12

    Google Scholar 

  10. Burkhalter A, Widmer LK, Glans L (1974) Chronischer Gliedmaßenverschluß und Langzeitantikoagulation. VASA 3:185–189

    PubMed  CAS  Google Scholar 

  11. Comerota AJ, Stewart GJ, Alburger PD, Smalley K, White JV (1989) Operative venodilation. A previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery 106:301–309

    PubMed  CAS  Google Scholar 

  12. Comerota A J (1994) Operative venous dilatation and its relationship to postoperative deep vein thrombosis. In: Bergquist D, Comerota AJ, Nicolaides AN, Scurr JH (eds) Prevention of venous thromboembolism. MED-ORION, London, pp 31–38

    Google Scholar 

  13. Cunningham DA, Kumar B, Siegel BA, Gilula LA, Totty WG, Welsh MJ (1984) Aspirin inhibition of platelet deposition of angioplasty sites: Demonstration by platelet scintigraphy. Radiology 151:487–490

    PubMed  CAS  Google Scholar 

  14. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sei USA 90:1004–1008

    Article  Google Scholar 

  15. Edmonson RA, Cohen AT, Das SK, Wagner MB, Kakkar W (1994) Lowmolecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet 344:914–918

    Article  Google Scholar 

  16. Ehresmann U, Alemany J, Loew D (1977) Prophylaxe von Rezidiwerschlüssen nach Revaskularisationseingriffen mit Acetylsalicylsäure. Med Welt 28:1157–1162

    PubMed  CAS  Google Scholar 

  17. Freimann DB, Spence R, Gatenby R et al (1981) Transluminal angioplasty of the iliac and femoral arteries: Results without anticoagulation. Radiology 141:437–350

    Google Scholar 

  18. Fuster V, Chesebro JH (1986) Role of platelets and platelet inhibitors in aorto coronary vein graft disease. Circulation 73:227–232

    Article  PubMed  CAS  Google Scholar 

  19. Gallino A, Mahler F, Probst P, Nachbur B (1984) Percutaneous transluminal angioplasty of the arteries of the lower limbs. A 5 year follow up. Circulation 70:619–623

    Article  Google Scholar 

  20. Goldman MD, Simpson D, Hawker RJ, Norcott HC, McCollum CN (1983) Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man. Ann Surg 198:713–716

    Article  PubMed  CAS  Google Scholar 

  21. Greinacher A, Müller-Eckhardt C (1991) Therapie der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wochenschr 116:1483–1484

    Article  PubMed  CAS  Google Scholar 

  22. Hach-Wunderle V, Scharrer I (1993) Prävalenz des hereditären Mangels an Antithrombin III, Protein C und Protein S. Dtsch Med Wochenschr 118:187–190

    Article  PubMed  CAS  Google Scholar 

  23. Heiss HW, Just H, Middleton D, Deichsel G (1990) Reocculsion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA. Angiology:263–269

    Google Scholar 

  24. Hess H (1967) Die Antikoagulantien- und Fibrinolyse-behandlung bei arteriellen Gefäßverschlüsse. Therapiewoche 17:1617–1619

    Google Scholar 

  25. Hess H, Mietaschk A, Deichsel G (1985) Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. Lancet 1:415–419

    Article  PubMed  CAS  Google Scholar 

  26. Hess H, Müller-Fassbender H, Ingrisch H, Mietaschk M (1978) Verhütung von Wiederverschlüssen nach Rekanalisation obliterativer Arterien mit der Kathetermethode. Dtsch Med Wochenschr 103:1994–1997

    Article  PubMed  CAS  Google Scholar 

  27. Hess H, Keil-Kuri E (1975) Theoretische Grundlagen der Prophylaxe obliterierender Arteriopathien mit Aggregationshemmer und Ergebnisse einer Langzeitstudie mit ASS (Colfarit). In: Marx R, Breddin HK (Hrsg) Colfarit-Symposium III. Bayer, Köln, S 80–87

    Google Scholar 

  28. Holm J, Schersten T (1972) Anticoagulant treatment during and after embolectomy. Acta Chir Scand 138:683–687

    PubMed  CAS  Google Scholar 

  29. Hume M, Sevitt S, Thomas DP (1979) Venous thrombosis and pulmonary embolism. Harvard University Press, Cambridge

    Google Scholar 

  30. Hynes RO (1991) The complexity of platelet adhesion to extracellular matrices. Thrombos. Haemostase. 66:40

    CAS  Google Scholar 

  31. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease: The Framinham study. J Am Med Assoc 258:1183–1186

    Article  CAS  Google Scholar 

  32. Krepel VM, van Andel GJ, van Erp WFM, Breslau PJ (1985) Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long term results. Radiology 156:325–328

    PubMed  CAS  Google Scholar 

  33. Kretschmer G, Schemper M, Ehringer H, Wenzel E, Polterauer P, Marosi L, Minar E (1988) Influence of postoperative anticoagulant treatment on patient survival after femoro-popliteal vein bypass surgery. Lancet 1:797–799

    Article  PubMed  CAS  Google Scholar 

  34. Mahler F, Nachbur B, Probst P (1979) Die perkutane Katheterbehandlung arterieller Stenosen und Verschlüsse der unteren Extremitäten. Schweiz Rundsch Med Praxis 68:1250–1253

    CAS  Google Scholar 

  35. Mannarino E, Pasqualini L, Innocente S, Orlandi U, Scricciolo V, Lombardini R, Cinfetti G (1991) Efficacy of low-molecular-weight-heparin in the management of intermittent claudication. Angiology 42:1–7

    Article  PubMed  CAS  Google Scholar 

  36. McCann RL, Hagen PO, Fuchs JCA (1980) Asprin and dipyridamole decrease intimal hyperplasia in experimental vein grafts. Ann Surg 191:238–243

    Article  PubMed  CAS  Google Scholar 

  37. Meade TW et al (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1:1050–1053

    Article  PubMed  CAS  Google Scholar 

  38. Metke MP, Lie JT, Fuster V, Kaye JM (1979) Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol 43:1144–1148

    Article  PubMed  CAS  Google Scholar 

  39. Minar E, Ehringer H, Ahmadi R, Dudczak R, Poventa G (1987) Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: Investigations with indium-lll-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy. Thromb Haemostas 58(2):718–723

    CAS  Google Scholar 

  40. Nordström M, Lindblad B, Anderson H, Bergquist D, Kjellström T (1994) Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 308:891–894

    Article  PubMed  Google Scholar 

  41. Oblath RW, Buckley FO, Green RM, Schwartz SI, De Weese JA (1978) Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole. Surgery 84:37–44

    PubMed  CAS  Google Scholar 

  42. Planes A, Vochelle NV (1994) Venous stasis and trauma in hip surgery. In: Bergquist D, Comerota AJ, Nicolaides AN, Scurr JH (eds) Prevention of venous thromboembolism. MED-ORION, London, p 57

    Google Scholar 

  43. Prandoni P, Lensing AW A, Büller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, Ten Cate JW (1992) Deep vein thrombosis and the incidence of subsequent symptomatic cancer. NEJM 327:1128–1133

    Article  PubMed  CAS  Google Scholar 

  44. Ranke C, Creutzig A, Luska G et al (1994) Controlled trial of high versus low dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease. Clin Invest Med 72:673–680

    Article  CAS  Google Scholar 

  45. Ross R, Glomset JA (1973) Atherosclerosis and the smooth muscle cell. Science 180:1332–1339

    Article  PubMed  CAS  Google Scholar 

  46. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809

    Article  PubMed  CAS  Google Scholar 

  47. Saggau W (1977) Antikoagulantientherapie in der Gefäßchirurgie. In: Marx R, Thiess HL (Hrsg) Klinische und ambulante Anwendung klassischer Antikoagulanzien. Schattauer, Stuttgart New York, S 171–176

    Google Scholar 

  48. Schoop W (1984) Prognose und Prophylaxe der peripheren arteriellen Verschlußkrankheit. In: Trübestein C (Hrsg) Arterielle Verschlußkrankheit und tiefe Beinvenenthrombose. Thieme, Stuttgart New York, S 172–176

    Google Scholar 

  49. Sevitt A (1974) The structure and growth of valve-pocket thrombi in femoral veins. Clin Pathol 27:517–528

    Article  CAS  Google Scholar 

  50. Shulman AG (1990) Heparin and atheroscerlosis: an investigative report on the treatment of atherosclerosis. Biomed Pharamcother 44:303–306

    Article  CAS  Google Scholar 

  51. Sinzinger H, O’Grady J, Fitscha P (1988) Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole. J Int Med Res 16:39–43

    PubMed  CAS  Google Scholar 

  52. Spencer K, Freiman DB, Gotenby R et al (1981) Long term results of transluminal angioplasty of the iliac and femoral arteries. Arch Surg 116:1377–1386

    Article  Google Scholar 

  53. Stewart GJ, Alburger PD, Stone EA, Soszka TW (1983) Total hip replacement induces surgery to remote veins in a canine model. J Bone Joint Surg 65(A):97–102

    PubMed  CAS  Google Scholar 

  54. Stewart GJ, Siskin MC, Schaub RG et al (1987) Use of ultrasound for noninvasive study of blood vessel responsiveness. Amer J Physiol 253:671–679

    Google Scholar 

  55. Stewart GJ, Lachmann JW, Alburger PD, Ziskin MC, Philips CM, Jensen K (1990) Intraoperative venous dilation and subsequent development of deep vein thrombosis in patients undergoing total hip or total knee replacement. Ultrasound in Med Biol 16:133–140

    Article  CAS  Google Scholar 

  56. Stiegler H, Hess H, Mietasch K, Trampisch HJ, Ingrisch H (1984) Einfluß von Ticlopidin auf die periphere obliterierende Arteriopathie. Dtsch Med Wochenschr 109:1240–1243

    Article  PubMed  CAS  Google Scholar 

  57. Stokes KR, Strunk HM, Campbell DR, Gibbons GW, Wheeler HG, Clouse ME (1990) 5 year results of iliac and femoropopliteal angioplasty in diabetic patients. Radiology 174:977–982

    PubMed  CAS  Google Scholar 

  58. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453– 1456

    Article  PubMed  CAS  Google Scholar 

  59. Vitoux JF, Matieu JF, Roncato M, Fiessinger JN, Aiach M (1985) Heparin-associated thrombocytopenia treatment with low molecular weight heparin. Thromb Haemostas 55:37–39

    Google Scholar 

  60. Waibel P, Geering P (1981) Spätresultate bei Rekonstruktionen wegen Verschlußkrankheit der unteren Extremität. VASA 10:308–309

    PubMed  CAS  Google Scholar 

  61. Weichert W, Meents H, Abt K, Lieb H, Hach W, Krzywanek HJ, Breddin HK (1994) Acetylsalicylic acid-reocclusion-prophylaxis after angioplasty (ARPA-study). Vasa 23:57–65

    PubMed  CAS  Google Scholar 

  62. Yarnell JWG, Baker IA, Sweetnam PM et al (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart diasease. Circulation 83:836–844

    PubMed  CAS  Google Scholar 

  63. Zeitler E, Reichold J, Schoop W, Loew D (1973) Einfluß von Acetylsalicylsäure auf das Frühergebnis nach perkutaner Rekanalisation arterieller Obliterationen nach Dotter. Dtsch Med Wochenschr 98:1285–1288

    Article  PubMed  CAS  Google Scholar 

  64. Zeitler E, Richter E, Roth FJ, Schoop W (1983) Results of percutaneous transluminal angioplasty. Radiology 146:57–60

    PubMed  CAS  Google Scholar 

  65. Zeitler E, Feng G, Oldendorf M, Richter EI, Ritter W, Seyferth W (1989) Ergebnisse der perkutanen transluminalen Angioplastie. Herz 14:22–28

    PubMed  CAS  Google Scholar 

  66. Zekert F, Kohn P, Vormittag E (1976) Eine randomisierte Studie über die postoperative Thromboseprophylaxe mit Acetylsalicylsäure. Med Welt 27:1372–1373

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. K. Breddin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum Nürnberg-Nord, Flurstraße 17, 90340, Nürnberg, Deutschland, Germany

    E. Zeitler (Direktor emeritus) (Direktor emeritus)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Breddin, H.K. (1997). Hämostaseologie und Einflußfaktoren auf Entstehung und Verlauf von Gefäßkrankheiten. In: Zeitler, E. (eds) Arterien und Venen. Klinische Radiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60381-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60381-5_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64380-4

  • Online ISBN: 978-3-642-60381-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation